Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. | BMC Gastroenterol | 2023 | 38066437 | PubTator, text mining | PubMed |
| Comprehensive characterization of adipogenesis-related genes in colorectal cancer for clinical significance and immunogenomic landscape analyses. | Lipids Health Dis | 2023 | 38062499 | PubTator, text mining | PubMed |
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model. | Front Oncol | 2023 | 38053658 | PubTator, text mining | PubMed |
| Biomarkers and experimental models for cancer immunology investigation. | MedComm (2020) | 2023 | 38045830 | PubTator, text mining | PubMed |
| CAR-T cell therapy for hematological malignancies: History, status and promise. | Heliyon | 2023 | 38027932 | PubTator, text mining | PubMed |
| Reprogramming Cancer Cells to Antigen-presenting Cells. | Bio Protoc | 2023 | 38023788 | PubTator, text mining | PubMed |
| Deciphering tumor-infiltrating dendritic cells in the single-cell era. | Exp Hematol Oncol | 2023 | 38012715 | PubTator, text mining | PubMed |
| Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines. | Vaccines (Basel) | 2023 | 38005965 | PubTator, text mining | PubMed |
| Innate immune cellular therapeutics in transplantation. | Front Transplant | 2023 | 37994308 | PubTator, text mining | PubMed |
| A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells. | Cell Mol Immunol | 2023 | 37990034 | PubTator, text mining | PubMed |
| A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer. | Sci Rep | 2023 | 37978247 | PubTator, text mining | PubMed |
| Langerhans cell histiocytosis: current advances in molecular pathogenesis. | Front Immunol | 2023 | 37965340 | PubTator, text mining | PubMed |
| GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells. | J Immunol Res | 2023 | 37965271 | PubTator, text mining | PubMed |
| Regeneration of joint surface defects by transplantation of allogeneic cartilage: application of iPS cell-derived cartilage and immunogenicity. | Inflamm Regen | 2023 | 37964383 | PubTator, text mining | PubMed |
| Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy-An Observational Study. | Int J Mol Sci | 2023 | 37958800 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker. | Cancers (Basel) | 2023 | 37958409 | PubTator, text mining | PubMed |
| Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer. | BMC Gastroenterol | 2023 | 37950156 | PubTator, text mining | PubMed |
| Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. | BMC Cancer | 2023 | 37940859 | PubTator, text mining | PubMed |
| Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients. | Nat Commun | 2023 | 37938561 | PubTator, text mining | PubMed |
| Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging. | Front Immunol | 2023 | 37936700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=10